Summary
The Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in High-Risk and Very High-Risk Subjects Who Need Aortic Valve Replacement [CoreValve; NCT01240902] evaluated transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
- Cerebrovascular Disease
- Interventional Techniques & Devices
- Valvular Disease
- Cardiology Clinical Trials
- Cerebrovascular Disease
- Interventional Techniques & Devices
- Valvular Disease
- Cardiology
- Cardiology Clinical Trials
- © 2014 MD Conference Express®
Tools
Low 2-Year All-Cause Mortality and Major Stroke Rates after CoreValve Implantation
Permalink:
Table of contents
Cited By...
- No citing articles found.